SCHEMBL6802595

SCHEMBL6802595

C#CCOc1ccc(CCNC(=O)/C(=C/OC(F)F)c2ccc(C(F)(F)F)cc2)cc1OC

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.42
ALDH1A1 P00352 7/20 0.41
PPARD Q03181 3/20 0.41
PPARA Q07869 3/20 0.41
MAPT P10636 2/20 0.41
HPGD P15428 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
KDM4E B2RXH2 2/20 0.40
PPARG P37231 1/20 0.40
TP53 P04637 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA7 P43166 1/20 0.40
CA9 Q16790 1/20 0.40
CA14 Q9ULX7 1/20 0.40
PTGER1 P34995 1/20 0.40
ROCK2 O75116 1/20 0.40
ROCK1 Q13464 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6802596 1.00 GAA (0.42) GAAALDH1A1PPARDPPARAMAPT
SCHEMBL6795571 0.91 KMT2A (0.46) GAAALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL6799222 0.91 MAPT (0.48) GAAALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL6798690 0.91 ALDH1A1 (0.45) GAAALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL6800575 0.91 ALDH1A1 (0.51) GAAALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL6795575 0.91 KMT2A (0.46) GAAALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL6798687 0.91 ALDH1A1 (0.45) GAAALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL6800578 0.91 ALDH1A1 (0.51) GAAALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL6799219 0.91 MAPT (0.48) GAAALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL6802548 0.90 GAA (0.51) GAAALDH1A1PPARDPPARAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6762321-B2 SUCH AS N-(2-(3,4-DIMETHOXYPHENYL)ETHYL)-3-DIFLUOROMETHOXY-2-(4 -METHYLPHENYL)ACRYLAMIDE; FUNGICIDES SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2004-07-13 US disclosed
US-20030195354-A1 Amide compounds and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2003-10-16 US disclosed
EP-1295868-A1 AMIDE COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2003-03-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030195354-A1 Amide compounds and use thereof CBR1, CBR3, NAT1 GAA 2282/4885ALDH1A1 244/4885PPARD 1513/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.